Growth Metrics

DBV Technologies (DBVT) EBT Margin (2014 - 2026)

DBV Technologies (DBVT) reported EBT Margin of 5266.67% for Q1 2026, down 187917.0% year-over-year from N/an in Q1 2025, and up 23.59% on a QoQ basis from 6892.25% in Q4 2025.

DBV Technologies (DBVT) has 11 years of EBT Margin data on file, last reported at 5266.67% in Q1 2026.

  • Quarterly EBT Margin fell 187917.0% year-over-year to 5266.67% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 2883.42% (up 32386.0% YoY) and the FY2025 annual result came in at 2598.58%, up 14445.0% from the prior year.
  • EBT Margin rose to 5266.67% in Q1 2026 per DBVT's latest filing, from 6892.25% in the prior quarter.
  • Across five years, EBT Margin topped out at 3010.58% in Q4 2022 and bottomed at 6892.25% in Q4 2025.
  • The 5-year median for EBT Margin is 1506.8% (2022), against an average of 2031.61%.
  • The widest annual swing landed in 2022, when EBT Margin soared 347610 bps; it then plunged 437644 bps in 2024.
  • Tracing DBVT's EBT Margin over 5 years: stood at 3010.58% in 2022, then tumbled by 104 bps to 126.11% in 2023, then tumbled by 3470 bps to 4502.54% in 2024, then tumbled by 53 bps to 6892.25% in 2025, then gained by 24 bps to 5266.67% in 2026.
  • Per Business Quant, the three latest DBVT EBT Margin figures stand at 5266.67% (Q1 2026), 6892.25% (Q4 2025), and 1195.53% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -6.40%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 41.95%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 23.05%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 18.99%
10 DBV Technologies 8.00 Bn 7.77 Bn -3.90 Mn -5,266.67%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -5,266.67%
Dec 31, 2025 -6,892.25%
Sep 30, 2025 -1,195.53%
Jun 30, 2025 -2,850.38%
Mar 31, 2025 -3,387.50%
Dec 31, 2024 -4,502.54%
Sep 30, 2024 -2,839.74%
Jun 30, 2024 -2,852.37%
Mar 31, 2024 -1,940.09%
Dec 31, 2023 -126.11%
Sep 30, 2023 -705.56%
Jun 30, 2023 -1,059.00%
Mar 31, 2023 -937.15%
Dec 31, 2022 3,010.58%
Sep 30, 2022 -833.51%
Jun 30, 2022 -1,506.80%
Mar 31, 2022 -652.75%
Dec 31, 2021 -465.52%
Sep 30, 2021 -1,816.55%
Jun 30, 2021 -2,089.25%
Mar 31, 2021 -1,000.31%
Dec 31, 2020 3,259.49%
Sep 30, 2020 -744.30%
Jun 30, 2020 -1,335.18%
Mar 31, 2020 -866.80%
Sep 30, 2019 -1,190.75%
Dec 31, 2018 493.10%
Sep 30, 2018 -1,458.28%
Dec 31, 2015 -470.57%
Jun 30, 2015 -13,250.00%
Dec 31, 2014 -454.14%
Jun 30, 2014 -11,362.63%